Embecta Corp. (EMBC)
6.21
-0.06
(-0.96%)
USD |
NASDAQ |
Oct 19, 16:00
6.22
+0.01
(+0.16%)
After-Hours: 20:00
Embecta Enterprise Value : 1.635B for Oct. 19, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 19, 2026 | 1.635B |
| October 16, 2026 | 1.639B |
| October 15, 2026 | 1.649B |
| October 14, 2026 | 1.634B |
| October 13, 2026 | 1.635B |
| October 12, 2026 | 1.623B |
| October 09, 2026 | 1.606B |
| October 08, 2026 | 1.609B |
| October 07, 2026 | 1.618B |
| October 06, 2026 | 1.621B |
| October 05, 2026 | 1.617B |
| October 02, 2026 | 1.604B |
| October 01, 2026 | 1.612B |
| September 30, 2026 | 1.604B |
| September 29, 2026 | 1.610B |
| September 28, 2026 | 1.619B |
| September 25, 2026 | 1.618B |
| September 24, 2026 | 1.602B |
| September 23, 2026 | 1.600B |
| September 22, 2026 | 1.600B |
| September 21, 2026 | 1.584B |
| September 18, 2026 | 1.583B |
| September 17, 2026 | 1.578B |
| September 16, 2026 | 1.574B |
| September 15, 2026 | 1.572B |
| Date | Value |
|---|---|
| September 14, 2026 | 1.580B |
| September 11, 2026 | 1.563B |
| September 10, 2026 | 1.561B |
| September 09, 2026 | 1.574B |
| September 08, 2026 | 1.598B |
| September 04, 2026 | 1.612B |
| September 03, 2026 | 1.606B |
| September 02, 2026 | 1.606B |
| September 01, 2026 | 1.581B |
| August 31, 2026 | 1.575B |
| August 28, 2026 | 1.570B |
| August 27, 2026 | 1.565B |
| August 26, 2026 | 1.565B |
| August 25, 2026 | 1.568B |
| August 24, 2026 | 1.566B |
| August 21, 2026 | 1.580B |
| August 20, 2026 | 1.593B |
| August 19, 2026 | 1.591B |
| August 18, 2026 | 1.572B |
| August 17, 2026 | 1.574B |
| August 14, 2026 | 1.572B |
| August 13, 2026 | 1.573B |
| August 12, 2026 | 1.553B |
| August 11, 2026 | 1.560B |
| August 10, 2026 | 1.566B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Artivion, Inc. | 1.416B |
| Abbott Laboratories | 207.72B |
| AngioDynamics, Inc. | 459.98M |
| Alphatec Holdings, Inc. | 2.098B |
| AtriCure, Inc. | 2.731B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 21.10M |
| Revenue (Quarterly) | 271.70M |
| Total Expenses (Quarterly) | 250.60M |
| EPS Diluted (Quarterly) | 0.3606 |
| Gross Profit Margin (Quarterly) | 55.47% |
| Profit Margin (Quarterly) | 7.77% |
| Earnings Yield | 23.89% |
| Operating Earnings Yield | 73.35% |
| Normalized Earnings Yield | 34.46 |